Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Sny crawled date : 2021 - 05 - 03 save search
Ligand Reports First Quarter 2021 Financial Results
Published: 2021-05-03 (Crawled : 22:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
LGND | $72.59 0.1% 0.1% 140K
|
Health Technology
|
| O: 1.19%
H: 0.26%
C: -1.62%
financial results results report
Q1 2021: A Look at Biopharma’s Top 25 Companies by Market Cap
Published: 2021-05-03 (Crawled : 17:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.53%
H: 1.05%
C: 0.98%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.12%
H: 1.84%
C: 1.6%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.46%
H: 1.69%
C: 1.06%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 2.84%
H: 2.77%
C: 1.15%
biopharma
MoonLake Immunotherapeutics in-licenses potentially best-in-class Tri-specific Nanobody®,[6] Sonelokimab (M1095/ALX 0761) from Merck KGaA, Darmstadt, Germany, with goal of transforming treatment of inflammatory diseases driven by IL-17A and F
Published: 2021-05-03 (Crawled : 15:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
disease treatment potential license germany
Himalaya Therapeutics Announces Appointment of Howe Li as Chief Medical Officer
Published: 2021-05-03 (Crawled : 14:15) - prnewswire.com
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.39%
H: 0.09%
C: -0.85%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
Escient Pharmaceuticals Names Svetlana Makhni as Chief Financial Officer
Published: 2021-05-03 (Crawled : 14:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
Clinical Catch-Up: April 26-30
Published: 2021-05-03 (Crawled : 14:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
Denali Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
Published: 2021-05-03 (Crawled : 13:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
DNLI | $15.98 -3.74% -3.88% 1.5M
|
Health Technology
|
| O: -0.36%
H: 1.3%
C: -3.17%
financial results results
Kymera Therapeutics Presents Positive Late-Breaking Data from Non-Interventional Study in Patients with Hidradenitis Suppurativa at the Society for Investigative Dermatology 2021 Annual Meeting
Published: 2021-05-03 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
KYMR | $33.965 -3.29% -3.4% 630K
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: -4.46%
positive
AVROBIO Provides Regulatory Update on Investigational AVR-RD-01 for Fabry Disease
Published: 2021-05-03 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
AVRO | $1.205 -2.82% -2.9% 39K
|
Health Technology
|
| O: -1.71%
H: 0.17%
C: -17.42%
disease rd-05
Alnylam Announces Positive Early Results on Clinical Outcome Measures from ILLUMINATE-A Phase 3 Study of OXLUMO® (lumasiran)
Published: 2021-05-03 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.11%
H: 0.09%
C: -3.66%
positive results phase 3
Relay Therapeutics Expands Clinical Leadership Team with Addition of Tara O’Meara and Charles Ferté
Published: 2021-05-03 (Crawled : 11:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -4.18%
H: 1.62%
C: 1.41%
RLAY | $5.96 -2.46% -2.52% 2.4M
|
Health Technology
|
| O: 1.45%
H: 0.16%
C: -1.4%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.